James Hays
Cardiovascular Disease · Jackson, MSNPI 1295749919
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,298 of the $2,158 with a category attached, or 60.1%. Edwards Lifesciences accounts for 69.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,622 and has fallen 97.0% since, to $48 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in MS, where the typical reported total is $3,650.
Across 36 payments — averaging $59.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Boehringer Ingelheim$218
- Abiomed$125
- Lantheus Medical Imaging, Inc.$120
- Esperion Therapeutics, Inc.$84
- AstraZeneca$28
- plus $85 from 5 others
Across 23 payments — averaging $33,897 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$760K
- Amgen$20K
What the payments were for
- Travel & lodging$86040%
- Food & beverage$1,29860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 13 | $1,498 |
| Boehringer Ingelheim | 9 | $218 |
| Abiomed | 1 | $125 |
| Lantheus Medical Imaging, Inc. | 1 | $120 |
| Esperion Therapeutics, Inc. | 5 | $84 |
| AstraZeneca | 2 | $28 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Bayer | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Bracco Diagnostics Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,158 in reported general payments places this provider in the 30th percentile of 144 cardiovascular disease providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $213 |
| Carvedilol | 20 | $208 |
| Valsartan | 11 | $162 |
| Amiodarone Hcl | 12 | $67 |
| Amlodipine Besylate | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Jackson
- Donny StokesJackson$207K
- James BenslerJackson$64K
- Michael HallJackson$54K
- Tahsin QarqishJackson$39K
- Christopher LatourJackson$33K
- Varun SardarJackson$31K
- Olurotimi BaderoJackson$20K
- Michael PaymentJackson$16K
- James HaysJackson$16K
- Douglas HarkinsJackson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.